Scleroderma in association with the use of docetaxel (taxotere) for breast cancer

Clinical and Experimental Rheumatology

Volumn 19, Issue 2, 2001, Pages 197-200

  Hassett, G ^a   Harnett, P ^a   Manolios, N ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Drug induced scleroderma; Malignancy; Scleroderma; Taxotere

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DICLOFENAC; DOCETAXEL; ENALAPRIL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PACLITAXEL; PENICILLAMINE; PREDNISOLONE; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; ALOPECIA; ARTICLE; BREAST CANCER; CANCER INVASION; CASE REPORT; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; FEMALE; FLUID RETENTION; HUMAN; LIVER METASTASIS; LUNG METASTASIS; PRIORITY JOURNAL; SCLERODERMA; SKIN MANIFESTATION; SOLID TUMOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; SCLERODERMA, LOCALIZED; TAXOIDS;

EID: 0035032373     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Relationships between the structure of taxol analogues and their antimitotic activity
2. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer
3. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue
4. Keeling Acute cutaneous reactions to Docetaxel, a new chemotherapeutic agent
5. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
6. A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotheraoy for advanced breast cancer: A study of the EORTC Early Clinical Trials Group
7. Docetaxel (Taxotere): Single agent activity, development of combination treatment and reducing side effects
8. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: Final results of a randomized study of the European organization for research and treatment of cancer
9. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities
10. Phase 1 and pharmacokinetic study of Taxotere (RP56976: NSC 628503) given as a short intravenous infusion
11. Scleroderma in association with the use of bleomycin: A report of 3 cases
12. Cancer in systemic sclerosis
13. Cancer and scleroderma
14. Scleroderma and malignancy: An epidemiological study
15. Cancer and systemic sclerosis: An epidemiologic study
16. Malignancy in progressive systemic sclerosis: Association with breast carcinoma
17. Carcinoma of breast and scleroderma: Four further cases and a literature review